Correlation Between Pfizer and Hartford Multifactor

Can any of the company-specific risk be diversified away by investing in both Pfizer and Hartford Multifactor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Hartford Multifactor into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Hartford Multifactor Equity, you can compare the effects of market volatilities on Pfizer and Hartford Multifactor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Hartford Multifactor. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Hartford Multifactor.

Diversification Opportunities for Pfizer and Hartford Multifactor

0.07

Correlation Coefficient

Pfizer  Hartford Multifactor

Significant diversification

The 3 months correlation between Pfizer and Hartford is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Hartford Multifactor Equity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hartford Multifactor and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Hartford Multifactor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hartford Multifactor has no effect on the direction of Pfizer i.e., Pfizer and Hartford Multifactor go up and down completely randomly.

Pair Corralation between Pfizer and Hartford Multifactor

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Hartford Multifactor. In addition to that, Pfizer is 1.5 times more volatile than Hartford Multifactor Equity. It trades about -0.05 of its total potential returns per unit of risk. Hartford Multifactor Equity is currently generating about 0.02 per unit of volatility. If you would invest  5,068  in Hartford Multifactor Equity on December 28, 2024 and sell it today you would earn a total of  41.00  from holding Hartford Multifactor Equity or generate 0.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  Hartford Multifactor Equity

Pfizer Inc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Hartford Multifactor

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Hartford Multifactor Equity are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Hartford Multifactor is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Pfizer and Hartford Multifactor

The main advantage of trading using opposite Pfizer and Hartford Multifactor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Hartford Multifactor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hartford Multifactor will offset losses from the drop in Hartford Multifactor's long position.

The idea behind Pfizer Inc and Hartford Multifactor Equity pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.